ILMN
37
5
HPE
61
6
MU
36
5
SIG
49
6
TMO
47
3
CAH
53
6
HOG
33
4
DTE
54
4
CVX
44
-2
EQIX
62
2
ISRG
76
2
CI
52
7
AXP
69
3
BK
72
4
GWW
71
4
ROK
47
-8
NWS
69
7
RRC
59
-4
RL
68
3
V
66
6
ILMN
37
5
HPE
61
6
MU
36
5
SIG
49
6
TMO
47
3
CAH
53
6
HOG
33
4
DTE
54
4
CVX
44
-2
EQIX
62
2
ISRG
76
2
CI
52
7
AXP
69
3
BK
72
4
GWW
71
4
ROK
47
-8
NWS
69
7
RRC
59
-4
RL
68
3
V
66
6
Financhill
Back

Adverum Biotechnologies Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29

ADVM
Adverum Biotechnologies

Last Price:
6.05
Seasonality Move:
22.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Adverum Biotechnologies Price Quote

$6.05
+0.30 (+5.22%)
(Updated: November 22, 2024 at 5:55 PM ET)

Adverum Biotechnologies Key Stats

Sell
29
Adverum Biotechnologies (ADVM) is a Sell
Day range:
$5.70 - $6.16
52-week range:
$5.70 - $29.70
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.83%
Volume:
873.6K
Avg. volume:
212.9K
1-year change:
-33.14%
Market cap:
$119.6M
Revenue:
$3.6M
EPS:
$-6.01

How Much Does Adverum Biotechnologies Make?

Data Unavailable

Is Adverum Biotechnologies Growing As A Company?

Data Unavailable

Adverum Biotechnologies Stock Price Performance

What Is Adverum Biotechnologies 52-Week High & Low?

Adverum Biotechnologies Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Adverum Biotechnologies?

Is Adverum Biotechnologies Cash Flow Positive?

  • What Is ADVM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$85.5M
  • What Is Adverum Biotechnologies’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $119.9M
  • What Is Adverum Biotechnologies’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$47.6M

Adverum Biotechnologies Return On Invested Capital

  • Is Management Doing A Good Job?
    ADVM return on invested capital is -69.14%
  • What Is Adverum Biotechnologies Return On Assets?
    ROA measures how assets are converting to revenues and is -41.8%
  • What Is ADVM Return On Equity?
    ROE is a measure of profitability and is -69.14%

Adverum Biotechnologies Earnings Date & Stock Price

Adverum Biotechnologies Competitors

Adverum Biotechnologies Dividend Yield

Adverum Biotechnologies Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0.13%
Revenue: 0% 1500%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 30.29
Upside from Last Price: 426.71%

Major Shareholders

  • How many ADVM shares are owned by institutional investors?
    52.5M ADVM shares are owned by institutional investors
  • How many ADVM shares are owned by insiders?
    6.4M ADVM shares are owned by insiders